O-RAN-ALLIANCE
14.12.2022 18:47:40 CET | Business Wire | Press release
The O-RAN Global PlugFest Fall 2022 was successfully completed in 6 venues across Asia, Europe, and North America, with 106 participating companies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221214005850/en/
O-RAN ALLIANCE global PlugFests represent a major platform enabling efficient progress of the O-RAN ecosystem through well-organized testing and integration. O-RAN Global PlugFest Fall 2022 is the second O-RAN PlugFest this year. In combination with the Spring PlugFest, the 2022 O-RAN Global PlugFests span across 9 venues with 156 participants, of which many participated at more than one venue.
“Testing and integration at O-RAN PlugFests show increasing maturity of O-RAN technology in all regions,” said Linsheng Liao, O-RAN TIFG Co-chair and Senior Project Manager of CMRI. “Comparing the PlugFest results year to year, we are pleased to see major progress made by the O-RAN ecosystem in conformance and interoperability tests, as well as more advanced end-to-end and network automation scenarios. O-RAN PlugFests greatly contribute to developing commercially available O-RAN networks.”
O-RAN Global PlugFest Fall 2022 in Asia
PlugFest in Japan, hosted by NTT DOCOMO, KDDI, Rakuten Mobile, SoftBank, YRP and YRP R&D Promotion Committee took place at multiple sites in large metropolitan area. Activities focused on:
- Lab tests and field trials of latency assurance with Near-RT RIC for E2E network slicing
- Conformance, IOT, E2E testing, including Open Fronthaul and security verification
- Field tests of mmW backhaul system using O-RAN Fronthaul
- Multi-vendor vRAN integration
- Near-RT RIC demo with xApp and E2 nodes
- Open source demo realizing vRAN application deployment with OpenStack Tacker
In addition to the hosts, participants included AMD AECG, Anritsu, ComWorth, Dell Technologies, DKK, DZS, Fujitsu, HCL, Keysight Technologies, KYOCERA, NEC, NVIDIA, Red Hat, Spirent, TOYO, VIAVI Solutions and Wind River.
PlugFest in South Korea hosted by LG Uplus focused on:
- 5G O-RAN in-building field trial
- 5G O-RAN Lab validation
- Test scenarios including fronthaul conformance test, E2E test, analysis of fronthaul and midhaul interfaces
- Validation of RIC use case with xApp/rApp and the open interfaces (O1, A1, and E2)
In addition to the hosts, participants included Ciena, DELL Technologies, ETRI, Innowireless, Juniper Networks, Keysight Technologies and Viettel High Technology Industries.
PlugFest in South Korea hosted by SK Telecom focused on:
- Open Fronthaul interface conformance testing for O-DU and O-RU
- O-RAN specified interoperability testing between O-DU and O-RU
- Evaluation of O-RAN based private 5G systems through O-RAN specified E2E tests
- Performance and functional testing in live indoor environments
In addition to the hosts, participants included ETRI, Hewlett Packard Enterprise, HFR, Intel and Keysight Technologies.
O-RAN Global PlugFest Fall 2022 in Europe
Deutsche Telekom, EANTC, EURECOM, Orange, TIM, Vodafone and BT have teamed up together with Telecom Infra Project (TIP) to host the Joint European O-RAN & TIP PlugFest Fall 2022. The PlugFest was hosted in four European labs, namely EURECOM in Sophia Antipolis, i14y Lab in Berlin, Orange Lab in Paris and TIM Innovation Lab in Torino.
The joint PlugFest has demonstrated complementarities and synergies between O-RAN and TIP as well as between the labs.
Test scenarios focused on:
- Conformance testing of Open Fronthaul interface of O-RU and O-DU
- End-to-end multi-vendor integration with functional and performance testing
- xApps/rApps integration with Near/Non-RT RICs and xApps/rApps functional verification
- O-Cloud platform performance testing
In addition to the hosts, participants included Aarna Networks, Accelleran, ADVA Optical Networking, Analog Devices, Anritsu, Aspire Technology, Azcom Technology, Calnex Solutions, Capgemini Engineering, Dell Technologies, DZS, Fujitsu, Hewlett Packard Enterprise, highstreet technologies, JMA Wireless, Juniper Networks, Keysight Technologies, Mavenir, Microamp Solutions, MTI, NEC, Net AI, Nokia, Open Networking Foundation, Radisys, Red Hat, Rimedo Labs, Rohde & Schwarz, SIAE MICROELETTRONICA, SOLiD, Spirent, VIAVI Solutions, VMware and VoerEir.
O-RAN Global PlugFest Fall 2022 in North America
PlugFest in North America hosted by CableLabs at the Kyrio OTIC Lab focused on:
- Multi-vendor O-RAN end-to-end system under test, based on the O-RAN E2E test specification, demonstrating cell capacity for signaling and user-plane traffic load. Moreover, the Fronthaul delay impact on user peak throughput was measured using Fronthaul impairment emulators.
- Demonstration of O-CU interoperability, based on the O-RAN IOT test specifications, verified traffic scenarios across emulated F1 and Xn interfaces, as well as the open F1 and Xn protocol implementation. In addition, the O-CU demonstrated successful interoperability for F1AP and XnAP global, elementary, and mobility procedures.
- Near-RT RIC testing for conformance to the O-RAN E2 interface specification (E2AP, E2 SM, E2 SM RC, and E2 SM KPM procedures) were verified following the E2 test specification. Moreover, a QoS xApp was integrated and tested.
In addition to the hosts, participants included Calnex Solutions, Capgemini Engineering, Lumentum Holdings, Radisys Networks, Sunwave Communications, VIAVI Solutions and Xena Networks.
PocFest in North America hosted by UNH-IOL, hosted by AT&T and DISH, took place in four labs:
- University of New Hampshire InterOperability Lab
- TIP Community Lab at Meta, Menlo Park CA
- POWDER Lab and NSF PAWR SITE with the University of Utah
- COSMOS Lab and NSF PAWR SITE with the Rutgers University, Columbia University, NYU Wireless
Activities focused on testing of conformance and performance of O-RU devices, measurements of energy saving and efficiency, integration of AI/ML for resource pooling and slicing, testing of RIC, xApps, SMO, and end-to-end interoperability testing.
In addition to the hosts, participants included AMD, Anritsu, Calnex, DZS, Fujitsu, HCL, Intel, Keysight Technologies, NEC, Radisys, Rohde & Schwarz, VIAVI Solutions, VVDN, VMware, Vodafone, Wind River and Xena.
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 330 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information, please visit www.o-ran.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221214005850/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom